BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 9707517)

  • 1. Effects of antipsoriatic therapies on hepatic microsomal enzyme activity in patients with psoriasis.
    Brockmeyer NH; Frühauf S; Mertins L; Barthel B; Goos M
    Eur J Med Res; 1998 Aug; 3(8):361-6. PubMed ID: 9707517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Influence of retinoids on the bioavailability of methoxy-8-psoralen].
    Beani JC; Bonnot D; Berthod F; Boitard M; Reymond JL; Beriel H; Amblard P
    Ann Dermatol Venereol; 1991; 118(4):273-5. PubMed ID: 2069337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [New aspects and developments in antipsoriasis retinoid therapy].
    Orfanos CE; Gollnick H; Tsambaos D
    Hautarzt; 1981 Jun; 32(6):275-80. PubMed ID: 7263232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparison of RePUVA and aromatic retinoid Ro 10-9359 with methotrexate in severe forms of psoriasis].
    Mashkilleysson AL; Mashkilleysson NA
    Hautarzt; 1983 May; 34(5):229-30. PubMed ID: 6862887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Dithranol and combined treatment procedures: pro and con].
    Mahrle G; Schulze HJ; Steigleder GK
    Hautarzt; 1985 Jan; 36(1):34-9. PubMed ID: 3972577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modifications of PUVA.
    Momtaz-T K; Fitzpatrick TB
    Dermatol Clin; 1995 Oct; 13(4):867-73. PubMed ID: 8785890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytotoxic and genotoxic effects of acitretin, alone or in combination with psoralen-ultraviolet A or narrow-band ultraviolet B-therapy in psoriatic patients.
    Silva FS; Oliveira H; Moreiras A; Fernandes JC; Bronze-da-Rocha E; Figueiredo A; Custódio JB; Rocha-Pereira P; Santos-Silva A
    Mutat Res; 2013 Apr; 753(1):42-7. PubMed ID: 23474391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of guttate and generalized psoriasis vulgaris: prospective randomized study.
    Caca-Biljanovska NG; V'lckova-Laskoska MT
    Croat Med J; 2002 Dec; 43(6):707-12. PubMed ID: 12476481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Laboratory and oligobiopsy studies of the liver in patients with psoriasis treated by the combination of Tigason-PUVA-cignoline (RePUVA+C)].
    Ruszczak Z; Biernat S; Prószyńska-Kuczyńska W; Drobnik G; Drobnik S
    Przegl Dermatol; 1989; 76(2):104-9. PubMed ID: 2695977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lenticular psoralen photoproducts and cataracts of a PUVA-treated psoriatic patient.
    Woo TY; Wong RC; Wong JM; Anderson TF; Lerman S
    Arch Dermatol; 1985 Oct; 121(10):1307-8. PubMed ID: 4037825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized double-blind trial of the treatment of chronic plaque psoriasis: efficacy of psoralen-UV-A therapy vs narrowband UV-B therapy.
    Yones SS; Palmer RA; Garibaldinos TT; Hawk JL
    Arch Dermatol; 2006 Jul; 142(7):836-42. PubMed ID: 16847198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Combined oral retinoid and PUVA therapy in the treatment of psoriasis and psoriatic arthropathy (author's transl)].
    Thivolet J; Robart S; Vignon E
    Ann Dermatol Venereol; 1981; 108(2):131-7. PubMed ID: 6972721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of fusidic acid on the hepatic cytochrome P450 enzyme system.
    Reimann G; Barthel B; Rockstroh JK; Spatz D; Brockmeyer NH
    Int J Clin Pharmacol Ther; 1999 Nov; 37(11):562-6. PubMed ID: 10584978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The function of the monooxygenase system of the liver in patients with psoriasis].
    Chichenina IV
    Vestn Dermatol Venerol; 1989; (8):32-5. PubMed ID: 2816028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phototoxicity and antipsoriatic effect of a topical methoxypsoralen solution in relation to the application time.
    Meffert H; Andersen KE; Sönnichsen N
    Photodermatol; 1984 Aug; 1(4):191-4. PubMed ID: 6531293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Topical corticosteroids and corticosteroid sparing therapy in psoriasis management].
    Sukarovska BG; Lipozencić J; Vrzogić P
    Acta Med Croatica; 2007 Sep; 61(4):375-81. PubMed ID: 18044472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of treatment with UV-light (365 nm) and 8-methoxypsoralen on chromosomes of healthy persons and psoriatic patients.
    Löber G; Kittler L; Beensen V; Schaarschmidt H; Knopf B
    Biomed Biochim Acta; 1986; 45(3):343-51. PubMed ID: 3707553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical therapy for psoriasis.
    Lebwohl M; Abel E; Zanolli M; Koo J; Drake L
    Int J Dermatol; 1995 Oct; 34(10):673-84. PubMed ID: 8537153
    [No Abstract]   [Full Text] [Related]  

  • 19. Topical 8-methoxypsoralen enhances the therapeutic results of targeted narrowband ultraviolet B phototherapy for plaque-type psoriasis.
    Asawanonda P; Amornpinyokeit N; Nimnuan C
    J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):50-5. PubMed ID: 18181973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction of treatment frequency and UVA dose does not substantially compromise the antipsoriatic effect of oral psoralen-UVA.
    Legat FJ; Hofer A; Quehenberger F; Kahofer P; Kerl H; Wolf P
    J Am Acad Dermatol; 2004 Nov; 51(5):746-54. PubMed ID: 15523353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.